Don't Search for a Hospital.
Find Your Treatment Path.
An intelligent platform comparing 90+ global cancer centers across advanced therapies, wait times, clinical trials, and true costs. We engineer the match between your case and the world's best oncology teams.
🎯 Which Cancer Center Fits Your Case?
Answer 5 simple questions. The system analyzes 90+ centers and suggests the top 5 compatible with your case, complete with a match score from 0-100.
🌍 Country Comparison — Interactive Dashboard
Compare 7 countries across advanced therapy availability, clinical trials, costs, and wait times.
Country-by-Country Therapy Access
| Country | Clinical Trials | CAR-T | TIL | NK | Gamma Delta | Radioligand | Wait Time | Int'l Access | Cost Rating | Trial Access Score™ |
|---|
💲 How Much Will Your Treatment Really Cost?
The cost isn't just the treatment. These are comprehensive estimates including accommodation, flights, translation, and visas.
⏱️ How Long Will You Wait to Start Treatment?
Time is precious. These are realistic estimates from first contact to treatment initiation, based on real data from partner centers.
Treatment Timeline by Country
| Country | First Appointment | Treatment Start | Trial Enrollment | Visa Processing | Total Estimated Time |
|---|---|---|---|---|---|
| 🇨🇳 China | 3-5 Days | 2-4 Weeks | 1-2 Weeks | 2-4 Weeks | 4-8 Weeks |
| 🇹🇷 Turkey | 5-7 Days | 3-5 Weeks | 2-4 Weeks | 1-2 Weeks | 5-9 Weeks |
| 🇮🇳 India | 3-7 Days | 2-4 Weeks | 2-3 Weeks | 1-2 Weeks | 4-8 Weeks |
| 🇰🇷 South Korea | 1-2 Weeks | 3-6 Weeks | 3-5 Weeks | 2-3 Weeks | 6-11 Weeks |
| 🇩🇪 Germany | 2-4 Weeks | 6-12 Weeks | 4-8 Weeks | 4-8 Weeks | 10-20 Weeks |
| 🇺🇸 USA | 4-8 Weeks | 8-16 Weeks | 6-12 Weeks | 8-12 Weeks | 16-28 Weeks |
🧬 Where Are Advanced Therapies Available?
An interactive, searchable matrix. 90+ hospitals — 8 advanced therapies.
Therapy Availability by Hospital
| Hospital | CAR-T | Dual CAR-T | NK | TIL | Gamma Delta | ADC | Radioligand | Bispecific |
|---|
🔬 Trial Access Index™
A proprietary CancerCareE index measuring clinical trial density and international patient access. Formula: Trial Density + Phase I Availability + International Enrollment + Access to Advanced Cellular Therapies.
Country Trial Access Rankings
| Country | Total Trials | CAR-T Studies | Cell Therapy Studies | Phase I Available | Int'l Enrollment | Trial Access Score™ |
|---|---|---|---|---|---|---|
| 🇨🇳 China | 22,000+ | 550+ | 850+ | Excellent | Open | 96 |
| 🇺🇸 USA | 20,000+ | 320+ | 420+ | Good | Limited | 82 |
| 🇩🇪 Germany | 5,500+ | 110+ | 160+ | Good | Limited | 74 |
| 🇰🇷 South Korea | 3,800+ | 80+ | 120+ | Good | Available | 70 |
| 🇬🇧 UK | 4,200+ | 65+ | 85+ | Average | Limited | 66 |
| 🇹🇷 Turkey | 2,200+ | 35+ | 45+ | Average | Open | 55 |
🎯 Where to Treat Rare Cancers?
Select the rare cancer type, and the system will suggest the best specialized centers globally.
💙 If This Were My Family™
What would I do if this were a family member? Educational scenarios — not medical advice.
ALL — Newly Diagnosed
→ I'd stay local. Standard treatment protocols are effective in 85-90% of cases. No need to travel initially. Induction chemotherapy is available at high quality in most countries.
ALL — Relapsed after 2 lines
→ I'd explore CAR-T. I'd look for approved CAR-T centers. China for speed and cost ($80k-$120k, 2-4 weeks). USA for standard of care ($400k-$500k, 8-16 weeks).
GBM — Recurred after standard care
→ I'd search for clinical trials. I'd focus on centers with a Trial Access Score above 70. Germany for EANO standards. China for more experimental options (CAR-T for brain, localized tumors).
Myeloma — Resistant to 3 lines
→ BCMA CAR-T. China has the highest density of BCMA CAR-T trials in the world. I'd also look into Dual-Target CAR-T at Bioocus Beijing.
Breast Cancer — Early Stage
→ I'd stay local. Surgery and adjuvant therapy are available at high quality in most countries. No benefit to traveling at this stage.
AML — with FLT3 mutation, relapsed
→ I'd explore experimental CAR-T. China has active CAR-T trials for AML with FLT3. I'd check eligibility at Bioocus Beijing and Soochow University Hospital.
Cholangiocarcinoma — Advanced
→ I'd search for Targeted Therapy trials. I'd focus on centers with FGFR and IDH1 trials. Fudan Shanghai and MD Anderson are strong options.
Sarcoma — Rare and metastatic
→ I'd look for a specialized sarcoma center. MD Anderson and Memorial Sloan Kettering in the USA. Fudan Shanghai in China. I'd check for TIL trials for sarcoma.
⚠️ Why Are International Patients Rejected?
No one tells you this. But knowing it saves you time, money, and frustration.
1. Incomplete or Untranslated Medical File
Without a complete pathology report, biomarkers, recent imaging, and accurate English translation — most centers won't even review your case.
2. Mismatched Biomarker
CAR-T needs CD19 or BCMA. TIL needs a resectable tumor. Without tests confirming the therapeutic target, you won't be eligible.
3. Low ECOG Performance Status
Most trials and advanced therapies require ECOG 0-2. If your general health is very poor (bedridden), you will be rejected.
4. Financial Mismatch
Some centers require proof of financial ability before acceptance. Without insurance or financial guarantee, you may not get an appointment.
5. No Suitable Open Trial
Even the best centers may not have an open trial for your exact cancer type right now. Trials fill up quickly.
6. Delay in Application
Promising trials fill up within weeks. Delay in preparing the file and applying is the number one reason for rejection.
🤖 Smart Observations from Analyzing 90+ Centers
Patterns discovered by our analysis system from partner center data.
CAR-T under $150,000
Patients looking for CAR-T with a budget under $150,000 often match with China or India. China offers approved and experimental CAR-T for $80,000-$120,000, India $70,000-$100,000.
GBM and Clinical Trials
Glioblastoma patients have the highest density of clinical trials in Germany and China. Germany for strict EANO standards, China for innovative CAR-T brain options and trials.
Fastest Access to Treatment
China offers the fastest time from evaluation to treatment initiation (2-4 weeks) compared to 8-16 weeks in the USA. The difference is due to the density of cellular manufacturing centers.
The True Cost of CAR-T
The price gap between China and the USA reaches $400,000 for the same treatment. CAR-T in China: $80,000-$120,000. In the USA: $400,000-$500,000. With comparable clinical outcomes.
Dual-Target CAR-T
Dual-Target CAR-T therapy (like CD19/CD22) is almost exclusively available in China within clinical trials. Bioocus Beijing is a leader in this field.
Arab Patients — Where do they go?
Turkey and India are the top destinations for Arab patients due to language support, visa ease, and moderate costs. China is an increasing option for those seeking advanced therapies at lower costs.
🏥 90+ Cancer Centers Worldwide
A searchable database. Choose country, cancer type, or therapy to find suitable centers.
🧬 What's the Next Step?
90+ cancer centers. 7 countries. Hundreds of clinical trials. Our team helps you understand the options available for your case — free and without obligation.
Response from an international oncology board • No fees • No obligation • Educational only
❓ Frequently Asked Questions
Common questions about finding the right cancer center and treatment pathway.
Use the AI Matching Engine at the top of this page. Enter your cancer type, stage, desired treatment, and budget. The system will suggest the top 5 hospitals compatible with your case with a match score from 0-100. The system analyzes 90+ hospitals across 7 countries based on their specialties, clinical trials, and costs.
India ($70,000-$100,000) and China ($80,000-$120,000) are the most affordable for CAR-T. Turkey ($100,000-$150,000) is a mid-range option. The USA ($400,000-$500,000) is the most expensive. The price gap reaches $400,000 for the same treatment.
In China: 2-4 weeks from evaluation to treatment initiation. In the USA: 8-16 weeks. The difference is due to the density of cellular manufacturing centers, speed of regulatory procedures, and bed availability in treatment centers.
Yes, many hospitals in China, the USA, and Germany accept international patients in their clinical trials. Use the Trial Access Index™ on this page to find centers with high trial access. China has the highest density of CAR-T trials in the world and accepts international patients.
The total cost includes: treatment + accommodation + flights + translation + visa. CAR-T in China: $83,000-$126,000. In the USA: $407,000-$512,000. Use the True Cost Calculator on this page for a personalized estimate.
A proprietary CancerCareE index measuring international patient access to clinical trials in each country. The formula: Trial Density + Phase I Availability + International Enrollment + Access to Advanced Cellular Therapies. China leads with 96/100.